TY - JOUR
T1 - New government drug repurposing programs
T2 - Opportunities and uncertainties
AU - Liddicoat, Johnathon
AU - Hamidzadeh, Ashleigh
AU - Liddell, Kathleen
AU - Schito, Marco
AU - Simon, David
AU - Aboy, Mateo
AU - Minssen, Timo
N1 - Publisher Copyright:
© 2024 The Authors.
PY - 2024
Y1 - 2024
N2 - Drug repurposing can be cheaper and faster than developing new compounds. Yet, it remains underused, partially because of regulatory and intellectual property challenges. Policy-makers in the United States and Europe have created seven drug development programs that aim to overcome these challenges using a variety of different strategies.
AB - Drug repurposing can be cheaper and faster than developing new compounds. Yet, it remains underused, partially because of regulatory and intellectual property challenges. Policy-makers in the United States and Europe have created seven drug development programs that aim to overcome these challenges using a variety of different strategies.
UR - http://www.scopus.com/inward/record.url?scp=85196945178&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.adl0998
DO - 10.1126/scitranslmed.adl0998
M3 - Review article
C2 - 38924430
AN - SCOPUS:85196945178
SN - 1946-6234
VL - 16
JO - Science translational medicine
JF - Science translational medicine
IS - 753
M1 - adl0998
ER -